|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▼
|
Status ▲
|
|
REPOTRECTINIB |
L01EX28 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006005 |
13-01-2025 |
VALID
|
|
VILOBELIMAB |
L04AJ10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006123 |
13-01-2025 |
VALID
|
|
CONCIZUMAB |
B02BX10 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005938 |
13-12-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, ADJUVANTED) |
J07BB02 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006538 |
15-11-2024 |
VALID
|
|
MIRVETUXIMAB SORAVTANSINE |
L01FX26 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005036 |
14-11-2024 |
VALID
|
|
MARSTACIMAB |
B02BX11 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/006240 |
19-09-2024 |
VALID
|
|
CHIKUNGUNYA VACCINES |
J07BX07 |
RO
|
POM
|
01-08-2025 |
EMEA/H/C/005797 |
28-06-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
RO
|
List I
|
14-05-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
RO
|
List I
|
15-11-2023 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B02BD16 |
RO
|
List I
|
|
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
RO
|
List I
|
03-10-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|
|
FARICIMAB |
S01LA09 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
VOCLOSPORIN |
L04AD03 |
RO
|
POM
|
21-11-2023 |
EMEA/H/C/005256 |
15-09-2022 |
VALID
|
|
VUTRISIRAN |
N07XX18 |
RO
|
POM
|
22-11-2023 |
EMEA/H/C/005852 |
15-09-2022 |
VALID
|
|
ASCIMINIB |
L01EA06 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
RO
|
List I
|
18-11-2022 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|